FDA and NIH Study: Population Assessment of Tobacco and Health

https://www.fda.gov/tobacco-products/research/fda-and-nih-study-population-assessment-tobacco-and-health?utm_campaign=ctp-path&utm_content=landingpage&utm_medium=email&utm_source=govdelivery&utm_term=stratcomms New PATH Study Data Files Available for Researchers New Wave 7 Biomarker Restricted-Use Files from the Population Assessment of Tobacco and Health (PATH) Study are now available from FDA’s Center for Tobacco Products and NIH’s National Institute on Drug Abuse. These Wave 7 files contain data collected between January 2022 and April 2023 from participants in the Wave 1, Wave 4, and Wave 7 Biomarker Cores. Researchers are encouraged to submit a request to obtain access. In addition to these newly released data files, researchers may also request access to all currently available Wave 1-Wave 7 Biomarker Restricted-Use Files and Questionnaire Restricted-Use Files. Data and documentation from the Public-Use Files are also available for download with updated Master Linkage Files. The PATH Study is a household-based, nationally representative, longitudinal study of youth (12-17 years old) and adults in the United States. The study was launched in 2011 to inform FDA’s regulatory activities under the Family Smoking Prevention and Tobacco Control Act. Questions about the collection, content, weighting, documentation, or structure of PATH Study data may be submitted to PATHDataUserQuestions@Westat.com.